ED2 LONG-TERM COST-UTILITY ANALYSIS OF INSULIN ASPART (NOVORAPID®) VERSUS HUMAN SOLUBLE INSULIN INTYPE 2 DIABETES PATIENTS IN THE GERMAN SETTING
G Goodall, WJ Valentine, C Townsend, R Kotchie, S Nielsen, K Erny-AlbrechtVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)64859-0
File:
PDF, 94 KB
english, 2007